Last reviewed · How we verify

Accutane — Competitive Intelligence Brief

Accutane (ISOTRETINOIN) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Retinoid [EPC]. Area: Oncology.

marketed Retinoid [EPC] Retinoic acid receptor alpha Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Accutane (ISOTRETINOIN).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Accutane TARGET ISOTRETINOIN marketed Retinoid [EPC] Retinoic acid receptor alpha 1982-01-01
AKLIEF® AKLIEF® Teva Pharmaceuticals USA marketed Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma
Adapalen Adapalen Technische Universität Dresden marketed Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha
differin differin University of Magdeburg marketed Aspartate aminotransferase, cytoplasmic, Glycine receptor subunit alpha-1, Retinoic acid receptor alpha
ATRA and or Chemo as maintenance ATRA and or Chemo as maintenance Groupe d'etude et de travail sur les leucemies aigues promyelocytaires phase 3 Retinoid; differentiation agent Retinoic acid receptor alpha (RARα)
Sohonos PALOVAROTENE Ipsen marketed Retinoid [EPC] Retinoic acid receptor gamma 2023-01-01
TRIFAROTENE TRIFAROTENE marketed Retinoid [EPC] 2019-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Retinoid [EPC] class)

  1. Bausch Health · 2 drugs in this class
  2. · 2 drugs in this class
  3. Chulalongkorn University · 1 drug in this class
  4. Galderma Labs Lp · 1 drug in this class
  5. Ipsen · 1 drug in this class
  6. Padagis LLC · 1 drug in this class
  7. Stiefel Labs Inc · 1 drug in this class
  8. Advanz · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Accutane — Competitive Intelligence Brief. https://druglandscape.com/ci/isotretinoin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: